NASDAQ:RNAC

Insiders Updates

Understanding the Risks of Investing in Cartesian Therapeutics Inc (RNAC)

Daniel Torres

Cartesian Therapeutics Inc’s recent filing unveils that its Director BARABE TIMOTHY C acquired Company’s shares for reported $0.21 million on ...

Insiders Updates

Short interest on RNAC sees a significant decrease on 2025-11-28

Anna Perez

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its ...

Knox Daily
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.